Investigation of type II phospholipase A(2 )values and eicosanoid values during polymyxin-B-immobilized fiber direct hemoperfusion of septic shock patients

Samankaltaisia teoksia

• Clinical efficacy of long-term performance with polymyxin-B immobilized fiber treatment for septic shock
  Tekijä: Matumoto, N, et al.
  Julkaistu: (2008)
• Re-evaluation of direct hemoperfusion with polymyxin-B immobilized fiber for severe sepsis and septic shock
  Tekijä: Matsuo, SM, et al.
  Julkaistu: (2011)
• Extended duration of direct hemoperfusion with polymyxin B-immobilized fiber column improves hemodynamics in patients with septic shock
  Tekijä: Yamashita, C, et al.
  Julkaistu: (2011)
• Up-to-date information on polymyxin B-immobilized fiber column direct hemoperfusion for septic shock
  Tekijä: Mitaka, Chieko, et al.
  Julkaistu: (2021)
• Observational study for direct hemoperfusion therapy with polymyxin-B immobilized fibers (PMX-DHP) in patients with septic shock in Japan: PMX-DHP study group
  Tekijä: Kase, Y, et al.
  Julkaistu: (2009)